CONCORD

Concord Drugs Share PriceConcord Drugs

₹26.45
0.3 (1.15%)
As on 25 March, 2023 | 06:03 BSE: 538965 NSE: CONCORD

Concord Drugs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Concord Drugs

Start SIP

Concord Drugs Share Price

  • Over 1 Month -11.83%
  • Over 3 Month -22.77%
  • Over 6 Month -18.49%
  • Over 1 Year -11.83%

Concord Drugs Key Statistics

Concord Drugs Investment Rating

  • Master Rating:
  • Concord Drugs has an operating revenue of Rs. 55.24 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 91 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Concord Drugs Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 14141315
Operating Expenses Qtr Cr 12131215
Operating Profit Qtr Cr 1111
Depreciation Qtr Cr 0100
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 0000

Concord Drugs Technicals

EMA & SMA

Current Price
₹26.45
0.3 (1.15%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 27.88
  • 50 Day
  • 29.24
  • 100 Day
  • 30.1
  • 200 Day
  • 30.24
  • 20 Day
  • 27.85
  • 50 Day
  • 29.69
  • 100 Day
  • 31.1
  • 200 Day
  • 29.88

Concord Drugs Resistance and Support

PIVOT
₹26.42
Resistance
First Resistance 26.74
Second Resistance 27.33
Third Resistance 27.65
RSI 40.18
MFI 23.29
MACD Single Line -0.75
MACD -0.83
Support
First Resistance 25.83
Second Resistance 25.51
Third Resistance 24.92

Concord Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,472 340,990 76.25
Week 3,686 313,786 85.12
1 Month 2,772 228,444 82.4
6 Month 8,604 509,450 59.21

Concord Drugs Result Highlights

Concord Drugs Synopsis

BSE-Medical-Diversified

Concord Drugs belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 58.96 Cr. and Equity Capital is Rs. 8.74 Cr. for the Year ended 31/03/2022. Concord Drugs Ltd. is a Public Limited Listed company incorporated on 24/04/1995 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24230TG1995PLC020093 and registration number is 020093.
Market Cap 23
Sales 55
Shares in Float 0.45
No of funds
Yield
Book Value 0.82
U/D Vol ratio 0.6
LTDebt / Equity 9
Alpha 0.02
Beta 0.21

Concord Drugs

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 49%49%49%
Individual Investors 50.71%50.67%50.67%
Others 0.29%0.33%0.33%

Concord Drugs Management

Name Designation
Mr. S Nagi Reddy Chairman & Managing Director
Mr. S Koni Reddy WholeTime Director & CFO
Mr. S Manoj Kumar Reddy Whole Time Director
Mr. S Nagavenkata Hareesh Independent Director
Mr. K Ramachandra Reddy Independent Director
Ms. Sumeela Kasu Independent Director

Concord Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Concord Drugs FAQs

What is Share Price of Concord Drugs ?

Concord Drugs share price is ₹26 As on 25 March, 2023 | 05:49

What is the Market Cap of Concord Drugs ?

The Market Cap of Concord Drugs is ₹23.1 Cr As on 25 March, 2023 | 05:49

What is the P/E ratio of Concord Drugs ?

The P/E ratio of Concord Drugs is 27.2 As on 25 March, 2023 | 05:49

What is the PB ratio of Concord Drugs ?

The PB ratio of Concord Drugs is 0.8 As on 25 March, 2023 | 05:49

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number